>
Switch to:

Molecular Templates PE Ratio

: At Loss (As of Today)
View and export this data going back to 2005. Start your Free Trial

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2021-09-28), Molecular Templates's share price is $7.43. Molecular Templates's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2021 was $-1.83. Therefore, Molecular Templates's PE Ratio for today is At Loss.


The historical rank and industry rank for Molecular Templates's PE Ratio or its related term are showing as below:

NAS:MTEM' s PE Ratio Range Over the Past 10 Years
Min: At Loss   Med: 0.89   Max: 6.96
Current: At Loss

At Loss
6.96

During the past 13 years, the highest PE Ratio of Molecular Templates was 6.96. The lowest was 0.00. And the median was 0.89.


NAS:MTEM's PE Ratio is ranked lower than
99.99% of the 268 Companies
in the Biotechnology industry.

( Industry Median: 34.00 vs. NAS:MTEM: At Loss )

Molecular Templates's Earnings per Share (Diluted) for the three months ended in Jun. 2021 was $-0.28. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2021 was $-1.83.

As of today (2021-09-28), Molecular Templates's share price is $7.43. Molecular Templates's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2021 was $-1.83. Therefore, Molecular Templates's PE Ratio without NRI for today is At Loss.

During the past 13 years, Molecular Templates's highest PE Ratio without NRI was 6.96. The lowest was 0.00. And the median was 0.89.

Molecular Templates's EPS without NRI for the three months ended in Jun. 2021 was $-0.28. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2021 was $-1.83.

During the past 3 years, the average EPS without NRI Growth Rate was -1.40% per year.

During the past 13 years, Molecular Templates's highest 3-Year average EPS without NRI Growth Rate was 85.50% per year. The lowest was -2.70% per year. And the median was 30.50% per year.

Molecular Templates's EPS (Basic) for the three months ended in Jun. 2021 was $-0.28. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2021 was $-1.83.


Molecular Templates PE Ratio Historical Data

The historical data trend for Molecular Templates's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molecular Templates Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
PE Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss At Loss

Molecular Templates Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
PE Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss At Loss

Competitive Comparison

For the Biotechnology subindustry, Molecular Templates's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Molecular Templates PE Ratio Distribution

For the Biotechnology industry and Healthcare sector, Molecular Templates's PE Ratio distribution charts can be found below:

* The bar in red indicates where Molecular Templates's PE Ratio falls into.



Molecular Templates PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Molecular Templates's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=7.43/-1.83
=At Loss

Molecular Templates's Share Price of today is $7.43.
Molecular Templates's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.83.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio or PE Ratio (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Molecular Templates  (NAS:MTEM) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Molecular Templates PE Ratio Related Terms

Thank you for viewing the detailed overview of Molecular Templates's PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Molecular Templates Business Description

Molecular Templates logo
Industry
Healthcare » Biotechnology NAICS : 325414 SIC : 2836
Traded in Other Exchanges
Address
9301 Amberglen Boulevard, Suite 100, Austin, TX, USA, 78729
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer.
Executives
French Douglas D 10 percent owner C/O 420 MAIN STREET EVANSVILLE IN 47708
Lalande Kevin M. director, 10 percent owner 201 WEST 5TH STREET AUSTIN TX 78701
Sante Health Ventures I Lp 10 percent owner C/O SHV MANAGEMENT SERVICES LP 300 WEST SIXTH STREET, SUITE 2300 AUSTIN TX 78701
Shv Management Services, Llc 10 percent owner FROST TOWER 401 CONGRESS AVENUE, SUITE 2950 AUSTIN TX 78701
Shv Management Services, Lp 10 percent owner FROST TOWER 401 CONGRESS AVENUE, SUITE 2950 AUSTIN TX 78701
Cunningham Joe H 10 percent owner C/O SHV MANAGEMENT SERVICES, LLC FROST TOWER, 401 CONGRESS AVE. STE. 2950 AUSTIN TX 78701
Sante Health Ventures I Annex Fund, Lp 10 percent owner 401 CONGRESS AVENUE, SUITE 2950 AUSTIN TX 78701
Shv Annex Services, Lp 10 percent owner 300 WEST 6TH STREET SUITE 2300 AUSTIN TX 78701
Enright Patrick G 10 percent owner CO LONGITUDE CAPITAL PARTNERS LLC 800 EL CAMINO REAL, SUITE 220 MENLO PARK CA 94025
Tammenoms Bakker Juliet 10 percent owner LONGITUDE CAPITAL MANAGEMENT CO., LLC 800 EL CAMINO REAL, SUITE 220 MENLO PARK CA 94025
Longitude Venture Partners Iii, L.p. 10 percent owner 800 EL CAMINO REAL, SUITE 220 MENLO PARK CA 94025
Longitude Capital Partners Iii, Llc 10 percent owner 800 EL CAMINO, SUITE 220 MENLO PARK CA 94025
Sanders Corazon (corsee) D. director C/O MOLECULAR TEMPLATES, INC. 9301 AMBERGLEN BLVD, SUITE 100 AUSTIN VI 78729
Selick Harold E director PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: SELICK HAROLD E a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}
Hirsch David director, 10 percent owner C/O LONGITUDE CAPITAL PARTNERS, LLC 800 EL CAMINO REAL, SUITE 220 MENLO PARK CA 94025

Molecular Templates Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)